These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30059410)
21. Changes in intraocular pressure after descemet stripping automated endothelial keratoplasty: a retrospective analysis. Müller L; Kaufmann C; Bachmann LM; Tarantino-Scherrer JN; Thiel MA; Bochmann F Cornea; 2015 Mar; 34(3):271-4. PubMed ID: 25625362 [TBL] [Abstract][Full Text] [Related]
22. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study. Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918 [TBL] [Abstract][Full Text] [Related]
23. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study. Lopes JF; Hubatsch DA; Amaris P BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363 [TBL] [Abstract][Full Text] [Related]
24. Use of Ocular Hypotensive Medications in Portugal: PEM Study: A Cross-sectional Nationwide Analysis. Sousa DC; Leal I; Nascimento N; Marques-Neves C; Tuulonen A; Abegão Pinto L J Glaucoma; 2017 Jun; 26(6):571-576. PubMed ID: 28368997 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of ocular surface complaints in Brazilian patients with glaucoma or ocular hypertension. Costa VP; Marcon IM; Galvão Filho RP; Malta RF Arq Bras Oftalmol; 2013; 76(4):221-5. PubMed ID: 24061832 [TBL] [Abstract][Full Text] [Related]
27. [Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy]. Gomes B; Turiel PR; Marques FP; Bernardo FP; Safady MV; Portes AL; Santhiago MR Arq Bras Oftalmol; 2013 Oct; 76(5):282-7. PubMed ID: 24232941 [TBL] [Abstract][Full Text] [Related]
28. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: a pilot study. Ventura LM; Porciatti V Ophthalmology; 2005 Jan; 112(1):20-7. PubMed ID: 15629815 [TBL] [Abstract][Full Text] [Related]
29. Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma. Chan PP; Leung CK; Chiu V; Gangwani R; Sharma A; So S; Congdon N Br J Ophthalmol; 2015 Sep; 99(9):1245-50. PubMed ID: 25733528 [TBL] [Abstract][Full Text] [Related]
30. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension. Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628 [TBL] [Abstract][Full Text] [Related]
31. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension. Easthope SE; Perry CM Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782 [TBL] [Abstract][Full Text] [Related]
32. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure. Choplin N; Bernstein P; Batoosingh AL; Whitcup SM; Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558 [TBL] [Abstract][Full Text] [Related]
33. Goldmann tonometry and pachymetry measures in patients with and without topical medical treatment at a glaucoma clinic. Doughty MJ; Gillis N; MacGill J; Montgomery DM Ophthalmic Physiol Opt; 2008 Nov; 28(6):558-67. PubMed ID: 19076558 [TBL] [Abstract][Full Text] [Related]
34. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Sallam A; Sheth HG; Habot-Wilner Z; Lightman S Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113 [TBL] [Abstract][Full Text] [Related]
35. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma. Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322 [TBL] [Abstract][Full Text] [Related]
36. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial. Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767 [TBL] [Abstract][Full Text] [Related]
37. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Coleman AL; Lerner F; Bernstein P; Whitcup SM Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719 [TBL] [Abstract][Full Text] [Related]
38. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group. Simmons ST; Samuelson TW Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361 [TBL] [Abstract][Full Text] [Related]
39. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France]. Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273 [TBL] [Abstract][Full Text] [Related]